Trial intelligence / Profile preview

Mechanisms of Lipodystrophy in HIV

NCT00457665Phase 4Completed

Sponsor
UT Southwestern Medical Center
Start
Feb 2002
Primary completion
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nelfinavir, efavirenz in human immunodeficiency virus infection (HIV), sponsored by UT Southwestern Medical Center. Started Feb 2002; status: completed.

02

Drugs

nelfinavirefavirenz
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00457665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00457665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call